Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals Revenue

Crinetics Pharmaceuticals had revenue of $1.97M in the twelve months ending March 31, 2024, down -53.93% year-over-year. Revenue in the quarter ending March 31, 2024 was $640.00K, a -76.11% decrease year-over-year. In the year 2023, Crinetics Pharmaceuticals had annual revenue of $4.01M, a decrease of -15.28%.

• Revenue (ttm): $1.97M
• Revenue Growth: -53.93%
• P/S Ratio: 1,819.28
• Revenue / Employee: $6,807
• Employees: 290
• Market Cap: 3.59B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.01M	-724.00K	-15.28%
Dec 31, 2022	4.74M	3.66M	339.42%
Dec 31, 2021	1.08M	1.01M	1,418.31%
Dec 31, 2020	71.00K	-1.12M	-94.05%
Dec 31, 2019	1.19M	-1.24M	-50.86%
Dec 31, 2018	2.43M	383.00K	18.73%
Dec 31, 2017	2.05M	1.46M	247.20%
Dec 31, 2016	589.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.